TITLE

New antibiotics class found

AUTHOR(S)
Robinson, Simon
PUB. DATE
May 2006
SOURCE
ICIS Chemical Business;5/29/2006, Vol. 1 Issue 21, p15
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article provides information on platensimycin, a potentially powerful weapon against antibiotic resistance discovered by Merck, Sharp and Dohme researchers. Platensimycin kills a wide range of Gram-positive bacteria, including so-called superbugs such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in mice. It also blocks enzymes involved in making fatty acids, the building blocks of cell membranes and bacterial surfaces.
ACCESSION #
21297666

 

Related Articles

  • New thiazolidones-4 with sulfamethizole-2 substituent as potential antifungal and antimicrobial preparations. Petrikaitė, Vilma; Tarasevičius, Eduardas; Pavilonis, Alvydas // Biologija;2007, Issue 3, p45 

    The growing number of semi-synthetic penicillin analogues and other antibiotics known to have the chemical structure of classic antimicrobial drugs (such as sulfonamides), as well as the increasingly pressing problem of bacterial resistance urged us to investigate new sulfanilamide derivatives....

  • Evolving gonococcal antimicrobial resistance: research priorities and implications for management. Hook III, Edward W.; Der Pol, Barbara Van // Sexually Transmitted Infections;Dec2013 Supplement, piv60 

    The combination of continually increasing minimum inhibitory concentration values, and outright resistance to the currently available treatments for Neisseria gonorrhoeae, and the paucity of new drugs in the developmental pipeline raises questions that require concentrated research attention at...

  • Too few antibiotics in pipeline. Rutledge, Barbara J. // Dermatology Times;Apr2005, Vol. 26 Issue 4, p1 

    The article focuses on the white paper issued by the Infectious Diseases Society of America. According to the paper, public health crisis is brewing, as two trends converge: the retreat of large and small pharmaceutical companies from antibiotic discovery and development, and the emergence of...

  • 10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America. Boucher, Helen W.; Talbot, George H.; Benjamin, Daniel K.; Bradley, John; Guidos, Robert J.; Jones, Ronald N.; Murray, Barbara E.; Bonomo, Robert A.; Gilbert, David // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1685 

    Infections caused by antibiotic-resistant bacteria, especially the “ESKAPE” pathogens, continue to increase in frequency and cause significant morbidity and mortality. New antimicrobial agents are greatly needed to treat infections caused by gram-negative bacilli (GNB) resistant to...

  • Antimicrobial metabolites and antibiotics obtained from different environmental sources. Kumar, Dheerendra; Kumar, Sunil // International Journal of Pharmaceutical Research & Allied Scienc;2016, Vol. 5 Issue 3, p85 

    This article compiles the history, sources and future prospects of antimicrobial metabolites and antibiotics. It is a brief overview of the antibiotic development through years and its emergence as life saving agents for everyone. Here, we also discussed the present situation of antibiotics and...

  • Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes. de Oliveira Junior, Nelson Gomes; e Silva Cardoso, Marlon Henrique; Franco, Octavio Luiz // Cellular & Molecular Life Sciences;Dec2013, Vol. 70 Issue 24, p4645 

    Gram-positive and -negative bacteria are dangerous pathogens that may cause human infection diseases, especially due to the increasingly high prevalence of antibiotic resistance, which is becoming one of the most alarming clinical problems. In the search for novel antimicrobial compounds, snake...

  • Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria. Chernysh, Sergey; Gordya, Natalia; Suborova, Tatyana // PLoS ONE;7/15/2015, Vol. 10 Issue 7, p1 

    In recent decades much attention has been paid to antimicrobial peptides (AMPs) as natural antibiotics, which are presumably protected from resistance development in bacteria. However, experimental evolution studies have revealed prompt resistance increase in bacteria to any individual AMP...

  • Where Are New Antibiotics Coming From? A Molecule-Centered Prospective. Vinall, Phil // MD Conference Express;Nov2012, p12 

    Information about the perspective on the treatment over microbial resistance aired at the 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) held in San Francisco, California on September 9-12, is presented. Topics include the need for promising chemical matter in the...

  • Recent developments in β lactamases and extended spectrum β lactamases. Samaha-Kfoury, Joumana N.; Araj, George F. // BMJ: British Medical Journal (International Edition);11/22/2003, Vol. 327 Issue 7425, p1209 

    Discusses the recent developments in β lactamases and extended spectrum β lactamases. Resistance to β lactam antibiotics as an increasing problem worldwide; Classification and mechanism of action of β lactamases; Options available for detecting, treating and controlling extended...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics